Back

Phenotype analysis reveals a “global collapse” cardiogenic shock signature despite VA-ECMO support in acute myocardial infarction – a subanalysis from ECLS-SHOCK

30 August 2026 (10:45 - 10:55)
Organised by: Logo
Congress Presentation Part of: Cardiogenic shock in acute myocardial infarction: new phenotypes and prognostic markers Cardiogenic Shock ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Tharusan Thevathasan

Charite University Hospital, Berlin (Germany)

5 More presentations in this session

Presentation thumbnail
Association of pre-existing sodium-glucose cotransporter-2 inhibitor therapy with outcomes in patients presenting with cardiogenic shock: a retrospective cohort study
Doctor M. Kunz (Basel, CH)
Abstract Slides
Presentation thumbnail
Prognostic value of serial SCAI staging in microaxial flow-pump-treated cardiogenic shock: impact of early hemodynamic trajectory on 30-day survival
Doctor J. Mierke (Dresden, DE)
Abstract Slides
Presentation thumbnail
Stroke-induced cardiac immune remodeling may influence cardiac outcomes in subsequent myocardial infarction
Doctor C. Liu (Shanghai, CN)
Abstract Slides
Presentation thumbnail
Hemodynamic profiles of STEMI patients at admission - prevalence and short-term outcomes of the novel PRESHOCK phenotype
Doctor S. Macherey-Meyer (Cologne, DE)
Abstract Slides
Presentation thumbnail
48-hour lactate-to-albumin ratio predicts 180-day mortality after microaxial flow pump support in cardiogenic shock
Doctor S. Kuroda (JP)
Abstract Slides

Access the full session

Session thumbnail
Cardiogenic shock in acute myocardial infarction: new phenotypes and prognostic markers
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 10:45 CET
You may be interested in
thumbnail
Congress Presentation
Distinct clinical phenotypes of cardiogenic shock an their association with in-hospital outcomes
20 March 2026
thumbnail
Congress Presentation
Efficacy and safety of cangrelor on top of anticoagulation in patients with myocardial infarction related cardiogenic shock or cardiac arrest receiving va ecmo: preliminary data from a phase 2 trial
20 February 2026
thumbnail
Congress Presentation
Prognostic value of baseline lactate levels in patients with infarct-related cardiogenic shock with and without ECLS therapy- a substudy of the ECLS-SHOCK trial
21 March 2026
thumbnail
Congress Session
Cardiogenic shock (2)
11 May 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources